Sensus Healthcare, Inc. - Common Stock (SRTS)
8.2350
+1.3650 (19.87%)
Sensus Healthcare Inc is a medical technology company that specializes in developing innovative solutions for the treatment of non-melanoma skin cancers and other dermatological conditions
The company focuses on providing non-invasive and effective therapies, particularly through its proprietary Sensus device that utilizes ultrasound technology for the precise targeting of cancerous tissues. In addition to skin cancer treatment, Sensus Healthcare also explores applications in other areas of oncology and dermatology, aiming to improve patient outcomes while minimizing side effects associated with traditional treatment methods. The company's commitment to research and development allows it to drive advancements in medical care, enhancing the quality of life for patients.